| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Budesonide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide systemic preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide adverse reaction |
Causative agent (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical budesonide adverse reaction |
Causative agent (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to budesonide (finding) |
Causative agent (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical budesonide allergy |
Causative agent (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide [gastro-intestinal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 3mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 2mg/100mL enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 400micrograms breath-actuated dry powder inhaler (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 500micrograms/2mL nebulization unit (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 1mg/2mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide refill 100dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide refill 200dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 50micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 100micrograms aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide Topical |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Respiratory budesonide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing budesonide in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 50mcg/dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 0.5mg/2mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 7g inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 32micrograms aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200mcg/spray powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 32mcg/spray spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 0.25mg/2 mL suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200micrograms inhaler with spacer device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide refill 100dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide refill 200dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 50micrograms aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 64mcg aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200mcg dry powder cartridge and refillable inhaler device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing budesonide and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 80mcg/formoterol 4.5mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 160mcg/formoterol 4.5mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 320mcg/formoterol 9mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200micrograms inhaler with spacer device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 200mcg dry powder cartridge refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol fumarate 200/6mcg bth-act dry pdr inh (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol fumarate 100/6mcg bth-act dry pdr inh (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide+eformoterol fumarate dihydrate 400micrograms/12micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 90micrograms dry powder for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 180micrograms dry powder for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to budesonide (finding) |
Causative agent (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical budesonide allergy |
Causative agent (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 3 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 50 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 64mcg conventional release nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Budesonide 3 mg gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 3 mg gastro-resistant oral capsule |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 3 mg oral capsule |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 100 microgram/actuation nasal spray |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 100 microgram/actuation nasal spray |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
Has precise active ingredient |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
Has basis of strength substance (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely budesonide 400 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely budesonide 400 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
Has precise active ingredient |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
Has basis of strength substance (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely budesonide 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely budesonide 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 200 microgram/actuation powder for inhalation |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 200 microgram/actuation powder for inhalation |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing budesonide in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing budesonide and formoterol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide and formoterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only budesonide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only budesonide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only budesonide in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only budesonide in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 50 microgram/actuation nasal spray |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 50 microgram/actuation nasal spray |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 200 microgram/actuation solution for inhalation |
Has basis of strength substance (attribute) |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Budesonide 200 microgram/actuation solution for inhalation |
Has precise active ingredient |
True |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has precise active ingredient |
False |
Budesonide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]